Clinical Trial Results: A Multiple Dose Study of LY3502970 in Healthy Overweight and Obese Participants [Phase 1]

View source ↗

Summary

Phase 1 multiple-dose study of LY3502970 in healthy overweight/obese participants completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• LY3502970

Snippet

Sponsor: Eli Lilly and Company | Conditions: Healthy, Obese | Phase 1 | Status: COMPLETED | Results posted: 2026-07-10